Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.

[1]  K. Oldroyd,et al.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. , 2010, Journal of the American College of Cardiology.

[2]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention , 2009 .

[3]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[4]  I. Ford,et al.  Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease , 2009, Circulation.

[5]  W. Gray,et al.  Fractional flow reserve for guiding PCI. , 2009, The New England journal of medicine.

[6]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[7]  U. Siebert,et al.  Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study. , 2007, American heart journal.

[8]  William Wijns,et al.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.

[9]  J. Granada,et al.  Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. , 2007, JAMA.

[10]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[11]  Patrick Hunziker,et al.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. , 2006, Journal of the American College of Cardiology.

[12]  G. Stone,et al.  Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. , 2006, Journal of the American College of Cardiology.

[13]  William Wijns,et al.  Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. , 2005, Journal of the American College of Cardiology.

[14]  N. Pijls.  Optimum guidance of complex PCI by coronary pressure measurement , 2004, Heart.

[15]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[16]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[17]  E. Topol,et al.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.

[18]  J. Alpert,et al.  [Universal definition of the myocardial infarction]. , 2008, Kardiologia polska.